Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Asthma Clinical Trials

A listing of Asthma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.


Found (455) clinical trials

AdheRence to Inhaled Corticosteroids in Asthma

The investigators will evaluate ARICA in Duke primary care clinics to study its feasibility and acceptability using a quasi-experimental pre-post study design. The study will enroll 32 adult African Americans with persistent asthma and suboptimal ICS adherence, and their health care providers, to study the use of the intervention and ...

Phase N/A


The aim of the study is to describe the prescribing pattern of the different types of medications which are used to treat asthma, across multiple countries.

Phase N/A

PK Linearity and Steady State PK of CHF 6532 in Healthy Subjects

The study consists in two parts. The first study part (Part I) is a single dose, randomised, double-blind, placebo-controlled, 5-way, 5-period crossover design, in healthy subjects. The second study part (Part II) is a repeated dose, open label treatment in healthy subjects. The PK of CHF 6532 and CHF 6532 ...


Study to Assess the Safety and Effectiveness of Beltavac Polymerised With House Dust Mites

This prospective open multi-center non-interventional study assess the safety and effectiveness profile of the subcutaneous allergen-specific immunotherapy with Beltavac polymerised with house dust mite pediatric allergic patients in routine medical care. Patients receive a rush schedule administration every month for a year. They attend at least 5 study visits to ...

Phase N/A

Aspirin for Uncontrolled Asthma

Asthma concerns about 7% of the French adult population. About 10% of them have uncontrolled disease, despite high doses of inhaled steroids combined with long acting beta 2 agonists and adequate management of aggravating factors. They account for considerable asthma morbidity, mortality and costs. New treatments are needed for these ...


Tezepelumab Home Use Study

The study will consist of a screening/run-in period of up to 2 weeks and a treatment period of 24 weeks, followed by a post-treatment follow-up period of 12 weeks. During the treatment period, one dose of 210 mg tezepelumab will be administered via a single-use APFS or AI subcutaneously (SC) ...


Post-marketing Surveillance (PMS) Study to Observe the Safety and Effectiveness of ARNUITY in Asthma Subjects in a Real World Setting

This is an open-label, multi-center, PMS study to observe the safety and effectiveness of ARNUITY administered in asthma subjects in a real world setting. This PMS shall observe how a broad range of subjects use the drug in the early stages after obtaining the approval. The objective of this PMS ...

Phase N/A

Child Asthma : What Parents Attitude During an Asthma Attack at Home Before Consulting the Pediatric Emergencies

prospective multicenter observational study. Parents whose children meet the inclusion criteria complete a questionnaire assessing the child's follow-up, the management of the current asthma attack, and the treatment provided at home. The main objective is to calculate the prevalence of placement of short-acting bronchodilators. The secondary objectives are to describe ...

Phase N/A

Kids 2 Be & Breathe: A Study on the Use of Yoga and Mindfulness in Children With Severe Asthma (K2B2)

Pre-Intervention Assessment: permission/assent from the child and consent of the parent/guardian will be obtained and initial data and measurements will be collected to ensure continued eligibility; baseline measures will be assessed. Intervention: participants will engage in a one-time manualized, age appropriate, 1:1, 30-minute intervention involving gentle yoga and mindfulness techniques ...

Phase N/A

Systemic Corticosteroids Avoidance Study in Severe Asthma Patients

The overall purpose of this study is to determine the efficacy of fevipiprant (dose 1 and dose 2 once daily), compared with placebo, as add-on to standard-of-care asthma therapy, in terms of avoidance of coricosteroid use over 52 weeks.